HIV-1 Env antibodies: are we in a bind or going blind?

HIV-1 Superinfection and its Implications for Vaccine Design

(2011) Bhavna H. Chohan et al.   CURRENT HIV RESEARCH

Safety and Efficacy of HIV Hyperimmune Globulin for Prevention of Mother-to-Child HIV Transmission in HIV-1–Infected Pregnant Women and Their Infants in Kampala, Uganda (HIVIGLOB/NVP STUDY)

(2011) Carolyne Onyango-Makumbi et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Statistical Interpretation of the RV144 HIV Vaccine Efficacy Trial in Thailand: A Case Study for Statistical Issues in Efficacy Trials

(2011) P. B. Gilbert et al.   JOURNAL OF INFECTIOUS DISEASES

Moving ahead an HIV vaccine: To neutralize or not, a key HIV vaccine question

(2011) Thomas J Hope   NATURE MEDICINE

Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody

(2011) D. R. Burton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

(2009) Supachai Rerks-Ngarm et al.   NEW ENGLAND JOURNAL OF MEDICINE

A STEP into Darkness or Light?

(2008) J. P. Moore et al.   SCIENCE